a

3S Corporation is one of India’s leading stockist, exporter & wholesaler for Anti-cancer drug & Oncology medicines. We even supply & export Sex Enhancement Drugs, Cardiac & Anti Diabetic Medicines. We are a registered wholesaler & exporter for pharmaceutical products licensed by our FDA and Drug Controller in India. Our license number are 20-B/MZ6-23015 & 21-B/ MZ6-23016.

+(91)-(22)-42643060

3scorp.india@gmail.com
Andheri East, Mumbai - 400099, India.

DISCLAIMER

All the pharmaceutical products we offer are prescription drugs and should be used/taken under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug. We are not an online pharmacy . We do not recommend any drug or give medical advice. We only express opinions and provide information. Whether a medication is right for you is a decision between you and the prescribing doctor. Kindly seek medical advice from a registered doctor 0r hospital/Institution before taking any of these medicines.

Monday - Saturday

10.00 - 19.00

+(91)-(22)-42643060

3scorp.india@gmail.com

Andheri East

Mumbai – 400099, India.

Eribulin Injection 0.88 mg

  •  anti-cancer agent

Description

Eribulin Injection 0.88 mg is an anti-cancer agent which works by stopping the growth and spread of cancer cells.

It is used for locally advanced or metastatic breast cancer (breast cancer that has spread beyond the original tumour) when at least one other therapy has been tried but has lost its effect.

India has many manufacturers who manufacture Eribulin Injection 0.88 mg  .To know more contact us.

3s corporation is supplier,Exporter ,Wholesaler  for Eribulin Injection 0.88 mg  in India.

Additional Information

Eribulin Injection 0.88 mg will be given to patient by a doctor or nurse as an injection into a vein, over a period of 2 to 5 minutes. The dose that patient will receive is based on patient body surface area (expressed in squared metres, or m2) which is calculated from patient’s weight and height. The usual dose of Eribulin Injection 0.88 mg is 1.23 mg/m2, but this may be adjusted by  doctor based on patient’s blood test results or other factors.

Side Effects

Very common side effects (reported in at least 1 out of 10 patients) are:

  • Decrease in the number of white blood cells or red blood cells
  • Tiredness or weakness
  • Nausea, vomiting, constipation, diarrhoea
  • Numbness, tingling or prickling sensations
  • Fever
  • Loss of appetite, weight loss
  • Difficulty breathing, cough
  • Pain in the joints and muscles and back
  • Headache
  • Hair loss

Common side effects (reported in at least 1 out of 100 patients) are:

  • Decrease in the number of platelets (which may result in bruising or taking longer to stop bleeding)
  • Infection with fever, pneumonia, chills
  • Fast heart rate, flushing
  • Vertigo, dizziness
  • Increased production of tears, conjunctivitis (redness and soreness of the surface of the eye), nosebleed
  • Dehydration, dry mouth, mouth ulcers, cold sores, oral thrush, indigestion, heartburn, abdominal pain or swelling
  • Swelling of soft tissues, pains (in particular chest, back and bone pain), muscle spasm or weakness
  • Mouth, respiratory and urinary tract infections, painful urination
  • Sore throat, sore or runny nose, flu-like symptoms, throat pain
  • Liver function test abnormalities, altered level of sugar, bilirubin, phosphates, potassium or magnesium in the blood
  • Inability to sleep, depression, changed sense of taste
  • Rash, itching, nail problems, dry or red skin
  • Excessive sweating (including night sweats)

Uncommon side effects (reported in less than 1 out of 100 patients) are:

  • Severe infections with blood poisoning (sepsis), shingles
  • Ringing in the ears
  • Blood clots
  • Abnormal liver function tests (hepatoxicity)
  • Swelling of the skin and numbness of the hands and feet
  • Kidney failure, blood or protein in the urine

Rare side effects (reported in less than 1 out of 1000 patients) are:

  • Inflammation of the pancreas
  • Widespread inflammation of the lungs which may lead to scarring
  • Widespread development of blood clots in the very tiny blood vessels with associated inability for the blood to clot in the bigger blood vessels leading to internal bleeding throughout the body

Pack Size